COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 940: Articles 9391-9400  | Next

T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components
Jing, L., Wu, X., Krist, M. P., Hsiang, T.-Y., Campbell, V. L., McClurkan, C. L., Favors, S. M., Hemingway, L. A., Godornes, C., Tong, D. Q., Selke, S., LeClair, A. C., Pyo, C.-W., Geraghty, D. E., Laing, L. J., Wald, A., Gale, M., Koelle, D. M.
10.1101/2022.01.23.22269497 — Posted: 2022-01-25
Death review caused by Covid 19 in Bangladesh
Biswas, R. S. R., Nath, J. D., Nisha, F. E.
10.1101/2022.01.23.22269626 — Posted: 2022-01-25
Effects of 12 weeks of Multi-nutrient supplementation on the Immune and Musculoskeletal systems of Older Adults in Aged-Care (The Pomerium Study): Protocol for a Randomised Controlled Trial
Al Saedi, A., Kirk, B., Iuliano, S., Zanker, J., Vogrin, S., Jayaram, L., Thomas, S., Golding, C., Navarro-Perez, D., Marusic, P., Leng, S., Nanan, R., Duque, G.
10.1101/2022.01.23.22269669 — Posted: 2022-01-25
The Epidemiology of Hundreds of Individuals Infected with Omicron BA.1 in Middle-Eastern Jordan
Hajjo, R., AbuAlSamen, M. M., Alzoubi, H. M., Alqutob, R.
10.1101/2022.01.23.22269442 — Posted: 2022-01-25
Forecasted trends of the new COVID-19 epidemic due to the Omicron variant in Thailand, 2022
Suphanchaimat, R., Teekasap, P., Nittayasoot, N., Phaiyarom, M., Cetthakrikul, N.
10.1101/2022.01.24.477479 — Posted: 2022-01-24
SARS-CoV-2 viremia precedes an IL6 response in severe COVID-19 patients: results of a longitudinal prospective cohort
Roy-Vallejo, E., Cardenoso, L., Triguero-Martinez, A., Chicot Llano, M., Zurita Cruz, N. D., Avalos Perez-Urria, E., Barrios, A., Hernando Santos, J., Ortiz, J., Rodriguez-Garcia, S. C., Ciudad Sanudo, M., Marcos, C., Garcia Castillo, E., Fontan Garcia-Rodrigo, L., Gonzalez, B., Mendez, R., Iturrate, I., Sanz-Garcia, A., Villa, A., Sanchez Azofra, A., Quicios, B., Arribas, D., Alvarez-Rodriguez, J., Patino, P., Trigueros, M., Uriarte, M., Martin Ramirez, A., Arevalo, C., Galvan-Roman, J. M., Garcia-Vicuna, R., Ancochea, J., Munoz-Calleja, C., Fernandez-Ruiz, E., de la Camara, R., Suarez Fernan
10.1101/2022.01.24.22269734 — Posted: 2022-01-24
Evidence on the role of journal editors in the COVID19 infodemic: metascientific study analyzing COVID19 publication rates and patterns
Grisi, G., Barreto Segundo, J. d. D., Freire, C. V., Matias, D., Cruz, M., Laporte, L. R., Medina, D., Taniguchi, T. M., Requiao, L., Goes, B., Correia, L. C. L.
10.1101/2022.01.23.22269716 — Posted: 2022-01-24
Estimated Fraction of Incidental COVID Hospitalizations in a Cohort of 250 High-Volume Hospitals Located in 164 Counties
Harris, J. E.
10.1101/2022.01.22.22269700 — Posted: 2022-01-24
Are allergic diseases a risk factor for systemic side effects after COVID-19 vaccines?
ATAYIK, E., Aytekin, G.
10.1101/2022.01.23.22269704 — Posted: 2022-01-24
Early Alveolar Epithelial Cell Necrosis is a Potential Driver of ARDS with COVID-19
Tojo, K., Natsuhiro, Y., Tamada, N., Mihara, T., Abe, M., Goto, T.
10.1101/2022.01.23.22269723 — Posted: 2022-01-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).